Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CDC Seeks Collaborator in Achieving Earlier HIV Detection
By Kelly A. Briganti, JD, Editorial Director, G2 Intelligence In keeping with Medicare's expanded coverage of HIV screenings aimed at achieving earlier detection of the virus (see National Intelligence Report, Feb. 12, 2015), the CDC is also focusing on earlier and...
LabCorp Completes $6.2 Billion Covance Acquisition
By Stephanie Murg, Managing Director of Conferences, G2 Intelligence LabCorp (Burlington, N.C.) has become the nation's largest provider of health care diagnostic services with its acquisition of contract research organization Covance (Princeton, N.J.). Announced...
Contractor Issues a Reminder on NPI Change
By Christopher P. Young, Editor, G2 Compliance Advisor Contractors sent all Medicare Part B providers a notice on Feb. 16 reminding them that effective April 1, laboratories submitting claims for reference laboratory or anti-markup tests will no longer include the...
Research By Ambry Genetics Expands Links To Breast, Ovarian Cancer Risk
By Ron Shinkman, Editor, Laboratory Industry Report Ambry Genetics, the California-based clinical laboratory, has published data concluding that the genetic risk to breast and ovarian cancer is not confined solely the BRCA gene. BRCA testing has been the gold...
Angels Looking to Fill Funding Gap in Early-Stage Medtech
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Early-stage investment capital is difficult to come by. But, with some notable acquisitions and initial public offerings making headlines in 2014, angel investors are looking with renewed...